Literature DB >> 20800628

RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain.

Sejin Son1, Do Won Hwang, Kaushik Singha, Ji Hoon Jeong, Tae Gwan Park, Dong Soo Lee, Won Jong Kim.   

Abstract

The work demonstrated the successful delivery of gene to mouse brain overcoming the blood-brain barrier (BBB) through expedient vector construct having RVG peptide as targeting ligand for neuronal cells. The newly developed delivery vector was designed to impart bioreducibility for greater intracellular pDNA release, higher serum stability and efficient complexing ability by incorporating disulfide linkage, PEG and low molecular weight polyethylenimine, respectively. The physiochemical properties of the polyplex, its cytotoxicity and the in vitro transfection efficiency on Neuro2a cell were studied prior to the successful in vivo study. In vivo fluorescence assay substantiated the permeation of the pDNA loaded polymeric vector through the BBB. The RVG-mediated target-specific cellular uptake of polymeric vector was established conclusively by competitive assay.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800628     DOI: 10.1016/j.jconrel.2010.08.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  23 in total

1.  A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system.

Authors:  Rebecca L Cook; Kyle T Householder; Eugene P Chung; Alesia V Prakapenka; Danielle M DiPerna; Rachael W Sirianni
Journal:  J Control Release       Date:  2015-10-22       Impact factor: 9.776

2.  Delivery and tracking of quantum dot peptide bioconjugates in an intact developing avian brain.

Authors:  Rishabh Agarwal; Miriam S Domowicz; Nancy B Schwartz; Judy Henry; Igor Medintz; James B Delehanty; Michael H Stewart; Kimihiro Susumu; Alan L Huston; Jeffrey R Deschamps; Philip E Dawson; Valle Palomo; Glyn Dawson
Journal:  ACS Chem Neurosci       Date:  2015-03-05       Impact factor: 4.418

Review 3.  Polymers in small-interfering RNA delivery.

Authors:  Kaushik Singha; Ran Namgung; Won Jong Kim
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

4.  Hexadecylated linear PEI self-assembled nanostructures as efficient vectors for neuronal gene delivery.

Authors:  Ruby Bansal; Brashket Seth; Shashikant Tiwari; Sadaf Jahan; Manisha Kumari; Aditya Bhushan Pant; Rajnish Kumar Chaturvedi; Pradeep Kumar; Kailash Chand Gupta
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

5.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

Review 6.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

7.  Fatty acid-based strategy for efficient brain targeted gene delivery.

Authors:  Jie Shen; Mei Yu; Qinggang Meng; Jin Li; Yifan Lv; Weiyue Lu
Journal:  Pharm Res       Date:  2013-04-23       Impact factor: 4.200

Review 8.  Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.

Authors:  Weisen Zhang; Ami Mehta; Ziqiu Tong; Lars Esser; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2021-03-07       Impact factor: 16.806

9.  Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; S Thayumanavan
Journal:  Biochemistry       Date:  2021-01-11       Impact factor: 3.162

Review 10.  Targeting Tumors with Small Molecule Peptides.

Authors:  Andrew G Cheetham; Daniel Keith; Pengcheng Zhang; Ran Lin; Hao Su; Honggang Cui
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.